Note J - Related Party	12 Months Ended
Dec. 31, 2017
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	NOTE J —RELATED PARTY Licensing Agreement with Subsidiaries of China Goldjoy Group Limited. On November 11, 2015 , BIO-key Hong Kong Limited, a subsidiary of the Company, entered into a license purchase agreement with certain subsidiaries of China Goldjoy Group Limited (“CGG”). The license agreement provides for the grant of a perpetual, irrevocable, exclusive, worldwide, fully-paid license to all software and documentation regarding the software code, toolkit, electronic libraries and related technology currently known as or offered under the Finger Q name, together with perpetual license under all related patents held by the licensors and any other intellectual property rights owned by the licensors related to the forgoing software. The Company made a one -time payment of $12,000,000 to the licensors. Mr. Yao Jianhu is the chairman and chief executive officer of CGG and a director of the Company. Mr. Wong Kwok Fong served as the chief technology officer of CGG through October 2016 and is the beneficial owner of 33.2% of the Company’s common stock, and a director and executive officer of the Company. Securities Purchase Agreement s with Wong Kwok Fong On November 18, 2016, the Company issued to Wong Kwok Fong, a director, executive officer and principal stockholder of the Company, 516,667 shares of common stock at a purchase price of $3.60 per share for gross cash proceeds of $1,860,000. On April 28, 2017, the Company issued to Wong Kwok Fong, a director and executive officer of the Company, 277,778 shares of common stock at a purchase price of $3.60 per share for gross cash proceeds of $1,000,000. On September 22, 2017, the Company issued to Wong Kwok Fong, a director and executive officer of the Company, 427,778 shares of common stock and warrants to purchase 138,889 shares of common stock for the aggregate purchase price of $1,540,000, or $3.60 per share. The purchase price was paid via a cash payment of $1,000,000 for 277,778 shares of common stock, and the conversion of an accrued dividend payable in the amount of $540,000 on the Company’s Series A- 1 Convertible Preferred Stock for 150,000 shares of common stock. On August 7, 2017, the Company received written notice from Wong Kwok Fong, the holder of an aggregate of 90,000 shares of the Company ’s Series A- 1 Convertible Preferred Stock, of his desire to increase the maximum percentage of shares of common stock issuable upon conversion of the Series A- 1 Convertible Preferred Stock from 9.99% to 35%. The Company waived a standstill provision to permit such increase. In accordance with the Certificate of Designation of the Series A- 1 Shares, such notice became effective on the 61st day following the date such notice was provided to the Company. On October 17, 2017, Wong Kwok Fong converted 27,404 of the Series A- 1 Shares at a conversion price of $3.60 per share resulting in the acquisition of 761,222 shares of the Company’s Common Stock

NOTE

—RELATED PARTY

Licensing Agreement with Subsidiaries of China Goldjoy Group Limited.

November 11, 2015

, BIO-key Hong Kong Limited, a subsidiary of the Company, entered into a license purchase agreement with certain subsidiaries of China Goldjoy Group Limited (“CGG”). The license agreement provides for the grant of a perpetual, irrevocable, exclusive, worldwide, fully-paid license to all software and documentation regarding the software code, toolkit, electronic libraries and related technology currently known as or offered under the Finger Q name, together with perpetual license under all related patents held by the licensors and any other intellectual property rights owned by the licensors related to the forgoing software. The Company made a

one

-time payment of

$12,000,000

to the licensors. Mr. Yao Jianhu is the chairman and chief executive officer of CGG and a director of the Company. Mr. Wong Kwok Fong served as the chief technology officer of CGG through

October 2016

and is the beneficial owner of

33.2%

of the Company’s common stock, and a director and executive officer of the Company.

Securities Purchase Agreement

with Wong Kwok Fong

November 18, 2016,

the Company issued to

Wong Kwok Fong, a director, executive officer and principal stockholder of the Company,

516,667

shares of common stock at a purchase price of

$3.60

per share for gross cash proceeds of

$1,860,000.

April 28, 2017,

the Company issued to Wong Kwok Fong, a director and executive officer of the Company,

277,778

shares of common stock at a purchase price of

$3.60

per share for gross cash proceeds of

$1,000,000.

September 22, 2017,

the Company issued to Wong Kwok Fong, a director and executive officer of the Company,

427,778

shares of common stock and warrants to purchase

138,889

shares of common stock for the aggregate

purchase price of

$1,540,000,

$3.60

per share. The purchase price was paid via a cash payment of

$1,000,000

for

277,778

shares of common stock, and the conversion of an accrued dividend payable in the amount of

$540,000

on the Company’s Series A-

Convertible Preferred Stock for

150,000

shares of common stock.

August 7, 2017,

the Company received written notice from Wong Kwok Fong, the holder of an aggregate of

90,000

shares of the Company

’s Series A-

Convertible Preferred Stock, of his desire to increase the maximum percentage of shares of common stock issuable upon conversion of the Series A-

Convertible Preferred Stock from

9.99%

35%.

The Company waived a standstill provision to permit such increase. In accordance with the Certificate of Designation of the Series A-

Shares, such notice became effective on the

61st

day following the date such notice was provided to the Company. On

October 17, 2017,

Wong Kwok Fong converted

27,404

of the Series A-

Shares at a conversion price of

$3.60

per share resulting in the acquisition of

761,222

shares of the Company’s Common Stock